Alzheimer’s Disease Psychosis (ADP) is a behavioral and psychological symptom that can occur in individuals living with Alzheimer’s disease. It is characterized by hallucinations (seeing, hearing, or sensing things that are not present) and delusions (false beliefs, often involving suspicion, fear, or misinterpretation of reality). These symptoms can be distressing both for the person affected and for caregivers, as they may lead to increased confusion, agitation, and difficulty with daily care.
ADP typically develops in the later stages of Alzheimer’s disease and can significantly impact quality of life, making specialized medical evaluation and treatment an important part of care.
We are seeking volunteers for a clinical study evaluating the safety and effectiveness of a treatment for Alzheimer’s Disease Psychosis (ADP). If you or someone you know may be interested, please contact us to learn more about eligibility and potential benefits.
Noble Clinical Research is now conducting a new Research Study for individuals for Alzheimer’s Disease Psychosis (ADP) and are looking for qualified research participants!
To qualify:
●Participants must be 55 to 90 years old
●Participants BMI ≥18.5 kg/m2 at time of screening
●Diagnose with Alzheimer’s Disease Psychosis
●Presence of psychotic symptoms for at least 2 months
Qualified participants will receive:
●up to $100 per clinic visit with no cost to you or your insurance!
●Regular check-ins and assessments to ensure your health is a priority.
●Study medications for are given at no cost.
Clinical Studies are running for:
Investigational Varicella Vaccine
Major Depressive Disorder
Eosinophilic Asthma
Severe Atopic Dermatitis
Osteoarthritis of the Knee
Future Studies
Noble Clinical Research
Call 520-612-7860 Now! Or Apply Directly on our Website
Refer a friend who qualifies, and you will receive a BONUS!
